🇺🇸 FDA

Drug profile · INN

lansoprazole

LANSOPRAZOLE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

lansoprazole (LANSOPRAZOLE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN lansoprazole
Brand LANSOPRAZOLE
Route ORAL
Formulation CAPSULE, DELAYED REL PELLETS, TABLET
Originator Takeda Pharmaceuticals International AG

Related patents

Search patents →

  1. US 9114085

    Modified release pharmaceutical compositions of dexlansoprazole

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8758818

    Oral tablet compositions of dexlansoprazole

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8753682

    Dual release oral tablet compositions of dexlansoprazole

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8741345

    Modified release pharmaceutical compositions of dexlansoprazole

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8563034

    Dual release oral tablet compositions of dexlansoprazole

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8563035

    Oral tablet compositions of dexlansoprazole

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7678816

    Method of stabilizing lansoprazole

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7622588

    Method for the purification of lansoprazole

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is lansoprazole?

lansoprazole (LANSOPRAZOLE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for lansoprazole?

LANSOPRAZOLE is a marketed brand name for lansoprazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of lansoprazole?

lansoprazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.